- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Industry News: Toshiba introduces Aquilion Premium
A less powerful version of Toshiba's flagship Aquilion One CT scanner appeared at its first tradeshow this week in Vienna.
A less powerful version of Toshiba's flagship Aquilion One CT scanner appeared at its first tradeshow this week in Vienna. The company is positioning the new scanner, dubbed Aquilion Premium, as a less costly and field upgradeable stepping stone to its 320-channel flagship.
The new release, scheduled to begin shipping next quarter, bears testament to the economic forces buffeting the CT industry. The product, presented at ECR as a posterboard exhibit, was initially slated for release at the Stanford MDCT conference in mid-May, but Toshiba strategists soft launched the product in January to get it in front of customers as soon as possible.
Aquilion Premium is priced at about 70% of the Toshiba flagship CT scanner that provides only half the coverage per rotation. Consequently, its 160-channel detector with an 8 cm width cannot capture an entire organ in a single rotation. This remains a unique attribute of the Aquilion One and its 320-channel, 16 cm detector. Toshiba executives are hoping the ability to upgrade Aquilion Premium in the field to the company’s flagship configuration will attract buyers.
In creating this sidekick to the Aquilion One, Toshiba fills the gap between its Aquilion 64 and top-of-the-line Aquilion One. The company has created similar gap fillers twice before. The first time the positioned an eight-slice Aquilion as a stepping stone to its 16- slice scanner. The second time positioned a 32-row detector as a field upgradeable alternative to 16- and 64-slice versions.
ECR Study Finds Mixed Results with AI on Breast Ultrasound
March 6th 2024While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.
Can Autonomous AI Help Reduce Prostate MRI Workloads Without Affecting Quality?
March 1st 2024Based on findings from a multicenter study of over 1,600 patients, researchers at the European Congress of Radiology suggest the inclusion of autonomous artificial intelligence (AI) triage could facilitate up to a 75 percent reduction in prostate MRI reading workload.
Five Insights on Artifacts and Limitations with Contrast-Enhanced Mammography
February 29th 2024Noting that technique issues, patient positioning miscues and atypical features can all contribute to faulty interpretation with contrast-enhanced mammography (CEM), researchers at the European Congress of Radiology shared their insights on navigating artifacts and limitations with CEM.
ECR Study Examines Key Predictive Factors for Metastasis in Patients with High-Risk Prostate Cancer
February 28th 2024Sixty-five percent of patients with newly diagnosed high-risk prostate cancer may have extraprostatic extension on MRI, and PSMA PET/CT findings suggest those with Gleason scores of eight or higher have more than double the risk of metastasis, according to a new study presented at the European Congress of Radiology (ECR).
